Table 2.
Gram-positive isolates resistant or intermediate-susceptibility to tested antimicrobials, overall and stratified by country
| Overall | Benin | Congo | Liberia | Madagascar | Sierra Leone | Togo | P value | |
| Staphylococcus aureus | 856 | 191 | 113 | 116 | 172 | 166 | 98 | |
| Oxacillin | 205 (23.9) | 66 (34.6) | 36 (31.9) | 24 (20.7) | 25 (14.5) | 40 (24.1) | 14 (14.3) | <0.001 |
| Gentamicin | 89 (10.4) | 29 (15.2) | 30 (26.5) | 7 (6.0) | 8 (4.7) | 9 (5.4) | 6 (6.1) | <0.001 |
| Ciprofloxacin | 162 (18.9) | 40 (20.9) | 26 (23.0) | 6 (5.2) | 49 (28.5) | 26 (15.7) | 15 (15.3) | <0.001 |
| TMP/SMX | 477 (55.7) | 110 (57.6) | 64 (56.6) | 26 (22.4) | 109 (63.4) | 113 (68.1) | 55 (56.1) | <0.001 |
| Clindamycin | 75 (8.8) | 3 (1.6) | 15 (13.3) | 9 (7.8) | 22 (12.8) | 11 (6.6) | 15 (15.3) | <0.001 |
| Enterococcus spp | 26 | 4 | 0 | 4 | 8 | 4 | 6 | |
| Ampicillin | 8 (30.8) | 0 (0.0) | 0 (0.0) | 2 (50.0) | 3 (37.5) | 2 (50.0) | 1 (16.7) | 0.420 |
| Gentamicin | 22 (84.6) | 4 (100.0) | 0 (0.0) | 1 (25.0) | 7 (87.5) | 4 (100.0) | 6 (100.0) | 0.009 |
| Ciprofloxacin | 10 (38.5) | 1 (25.0) | 0 (0.0) | 1 (25.0) | 4 (50.0) | 2 (50.0) | 2 (33.3) | 0.852 |
| Erythromycin | 17 (65.4) | 4 (100.0) | 0 (0.0) | 2 (50.0) | 6 (75.0) | 2 (50.0) | 3 (50.0) | 0.419 |
| Vancomycin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | – |
Presented as number (%).
P values from the Fisher exact test for categorical variables.
TMP/SMX, trimethoprim/sulfamethoxazole.